de Souza P - Search Results

1

Emerging roles for phospholipase A2 enzymes in cancer.

Scott KF, Sajinovic M, Hein J, Nixdorf S, Galettis P, Liauw W, de Souza P, Dong Q, Graham GG, Russell PJ. Scott KF, et al. Among authors: de souza p. Biochimie. 2010 Jun;92(6):601-10. doi: 10.1016/j.biochi.2010.03.019. Epub 2010 Mar 31. Biochimie. 2010. PMID: 20362028 Review.

2

A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.

Gan HK, Mitchell PL, Galettis P, Davis ID, Cebon J, de Souza P, Links M. Gan HK, et al. Among authors: de souza p. Cancer Chemother Pharmacol. 2006 Aug;58(2):157-64. doi: 10.1007/s00280-005-0152-y. Epub 2005 Nov 19. Cancer Chemother Pharmacol. 2006. PMID: 16328413 Clinical Trial.

3

Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol), a novel isoflav-3-ene, in patients with advanced cancer.

de Souza PL, Liauw W, Links M, Pirabhahar S, Kelly G, Howes LG. de Souza PL, et al. Cancer Chemother Pharmacol. 2006 Oct;58(4):427-33. doi: 10.1007/s00280-006-0189-6. Epub 2006 Feb 4. Cancer Chemother Pharmacol. 2006. PMID: 16463060 Clinical Trial.

4

Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation.

Grimison P, Galettis P, Manners S, Jelinek M, Metharom E, de Souza PL, Liauw W, Links MJ. Grimison P, et al. Among authors: de souza pl. J Clin Oncol. 2007 Dec 20;25(36):5704-9. doi: 10.1200/JCO.2007.10.7078. J Clin Oncol. 2007. PMID: 18089865 Clinical Trial.

5

Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells.

McPherson RA, Galettis PT, de Souza PL. McPherson RA, et al. Among authors: de souza pl. Br J Cancer. 2009 Feb 24;100(4):649-55. doi: 10.1038/sj.bjc.6604920. Epub 2009 Feb 10. Br J Cancer. 2009. PMID: 19209173 Free PMC article.

6

Role of the Akt pathway in prostate cancer.

de Souza PL, Russell PJ, Kearsley J. de Souza PL, et al. Curr Cancer Drug Targets. 2009 Mar;9(2):163-75. doi: 10.2174/156800909787581006. Curr Cancer Drug Targets. 2009. PMID: 19275757 Review.

7

Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer.

de Souza PL, Russell PJ, Kearsley JH, Howes LG. de Souza PL, et al. Nutr Rev. 2010 Sep;68(9):542-55. doi: 10.1111/j.1753-4887.2010.00314.x. Nutr Rev. 2010. PMID: 20796219 Review.

8

The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.

Metharom E, Galettis P, Manners S, Jelinek M, Liauw W, de Souza PL, Hoskins JM, Links M. Metharom E, et al. Among authors: de souza pl. Asia Pac J Clin Oncol. 2011 Mar;7(1):65-74. doi: 10.1111/j.1743-7563.2010.01354.x. Epub 2010 Dec 30. Asia Pac J Clin Oncol. 2011. PMID: 21332653 Clinical Trial.

9

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.

Becker TM, Caixeiro NJ, Lim SH, Tognela A, Kienzle N, Scott KF, Spring KJ, de Souza P. Becker TM, et al. Among authors: de souza p. Int J Cancer. 2014 Jun 1;134(11):2523-33. doi: 10.1002/ijc.28516. Epub 2013 Oct 29. Int J Cancer. 2014. PMID: 24122526 Free article. Review.

10

Circulating tumour cells--a bona fide cause of metastatic cancer.

Caixeiro NJ, Kienzle N, Lim SH, Spring KJ, Tognela A, Scott KF, de Souza P, Becker TM. Caixeiro NJ, et al. Among authors: de souza p. Cancer Metastasis Rev. 2014 Sep;33(2-3):747-56. doi: 10.1007/s10555-014-9502-8. Cancer Metastasis Rev. 2014. PMID: 24817039 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

794 results

Search Page